Cover Image
Market Research Report

United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Published by IMARC Services Private Limited Product code 821328
Published Content info 93 Pages
Delivery time: 2-3 business days
Price
Back to Top
United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
Published: April 8, 2019 Content info: 93 Pages
Description

The United States Specialty Generics Market reached a value of US$ 18.4 Billion in 2018. Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.

Specialty generics are economical compared to specialty drugs as they don't need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, as per the American cancer society, a total of 1,762,450 new cancer cases and 606,880 deaths from cancer are expected to occur in the United States in 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years. Looking forward, IMARC Group expects the market value to reach US$ 32.6 Billion by 2024, exhibiting a CAGR of around 10% during 2019-2024

Report Scope

Historical, Current and Future Market Trends

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape

The leading players in the US specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:

  • How has the US specialty generics market performed so far and how will it perform in the coming years?
  • What is the breakup of the US specialty generics market based on the route of administration
  • What is the breakup of the US specialty generics market based on the indication?
  • What is the breakup of the US specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the US specialty generics industry?
  • What are the key driving factors and challenges in the US specialty generics market?
  • What is the structure of the US specialty generics industry and who are the key players?
  • What is the degree of competition in the US specialty generics market?
Table of Contents
Product Code: SR1018F33_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

  • 4.1 What are Specialty Generic Drugs?
  • 4.2 Types of Specialty Generics

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Market Breakup by Route of Administration
  • 6.4 Market Breakup by Indication
  • 6.5 Market Breakup by Distribution Channel
  • 6.6 Market Breakup by Region
  • 6.7 Market Forecast

7 US Specialty Generics Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Breakup by Route of Administration
  • 7.4 Market Breakup by Indication
  • 7.5 Market Breakup by Distribution Channel
  • 7.6 Market Forecast
  • 7.7 SWOT Analysis
    • 7.7.1 Overview
    • 7.7.2 Strengths
    • 7.7.3 Weaknesses
    • 7.7.4 Opportunities
    • 7.7.5 Threats
  • 7.8 Value Chain Analysis
  • 7.9 Porters Five Forces Analysis
    • 7.9.1 Overview
    • 7.9.2 Bargaining Power of Buyers
    • 7.9.3 Bargaining Power of Suppliers
    • 7.9.4 Degree of Competition
    • 7.9.5 Threat of New Entrants
    • 7.9.6 Threat of Substitutes
  • 7.10 Key Market Drivers and Success Factors

8 Market Breakup by Route of Administration

  • 8.1 Injectables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.1 Market Forecast

9 Market Breakup by Indication

  • 9.1 Oncology
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Autoimmune Diseases
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Infectious Diseases
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Retail Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Specialty Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Hospital Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2018
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2018
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2018
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2018
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 7: US: Specialty Generics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 8: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2018
  • Figure 9: US: Specialty Generics Market: Breakup by Indication (in %), 2018
  • Figure 10: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2018
  • Figure 11: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 12: US: Specialty Generics Industry: SWOT Analysis
  • Figure 13: US: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 14: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2013 & 2018
  • Figure 15: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 16: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2013 & 2018
  • Figure 17: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2013 & 2018
  • Figure 19: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 20: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2013 & 2018
  • Figure 21: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 22: US: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Million US$), 2013 & 2018
  • Figure 23: US: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 24: US: Specialty Generics Market (Infectious Diseases): Sales Value (in Million US$), 2013 & 2018
  • Figure 25: US: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 26: US: Specialty Generics Market (Other Indications): Sales Value (in Million US$), 2013 & 2018
  • Figure 27: US: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 28: US: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2013 & 2018
  • Figure 29: US: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2019-2024
  • Figure 30: US: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2013 & 2018
  • Figure 31: US: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2019-2024
  • Figure 32: US: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2013 & 2018
  • Figure 33: US: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 2: US: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
  • Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2019-2024
  • Table 4: US: Specialty Generics Market Forecast: Breakup by Indication (in Million US$), 2019-2024
  • Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
  • Table 6: US: Specialty Generics Market Structure
  • Table 7: US: Specialty Generics Market: Key Players
Back to Top